Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-03-04

Clinical Trial Update: Clinical Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of HT31-1 for Treating ARDS [Phase 1]

View source ↗

Summary

Phase 1 clinical trial to evaluate the safety, tolerability, and pharmacokinetics of HT31-1 for acute respiratory distress syndrome; currently not yet recruitin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HT31-1

Snippet

Sponsor: HTIC, Inc | Conditions: ARDS (Acute Respiratory Distress Syndrome) | Phase 1 | Status: NOT_YET_RECRUITING